Fibromyalgia News

SAN DIEGO — Guidelines from three countries for the diagnosis, classification and clinical care regarding fibromyalgia focused on patient self-management of the condition, according to research presented at the American College of Rheumatology annual meeting.

SAN DIEGO — Patients with fibromyalgia and comorbid depression who were treated with pregabalin and antidepressant medication had significant improvement in pain, according to research presented at the American College of Rheumatology annual meeting.

SAN DIEGO — Research on dermatologic manifestations of fibromyalgia previously not reported was presented by Valerie Laniosz, MD, PhD, second-year dermatology resident at Mayo Clinic, Rochester, Minn., during the American College of Rheumatology annual meeting.

SAN DIEGO — Young and middle-aged patients with fibromyalgia experienced poorer quality of life and worse symptoms than older patients, according to research presented at the American College of Rheumatology annual meeting.

While patients with celiac disease had more than a 10% chance of developing fibromyalgia, patients with fibromyalgia had the same prevalence of celiac disease as the general population, according to recent study results.

Patients with hypothalamic-pituitary disorders appeared to be at increased risk for fibromyalgia-associated symptoms, according to recent study results.

Patients with fibromyalgia who had received milnacipran therapy for an average of 3 years had a greater loss of therapeutic response when switched to placebo compared with those who continued treatment, according to recent study results.

Almost half of patients diagnosed with fibromyalgia tested positive for small-fiber polyneuropathy, a peripheral nerve disease that might cause their chronic widespread pain, according to recent study results.

Patients with fibromyalgia syndrome reported varied levels of treatment satisfaction that were predicted by specific patient-related factors, according to study results.

Mid-infrared microspectroscopy was more effective than metabolic analysis in analyzing blood spots to accurately differentiate patients with fibromyalgia from those with rheumatoid arthritis or osteoarthritis, according to study results.